A prospective observational study on safety and efficacy of metformin and its combination used in type-ii diabetes mellitus patients

  • M Ganesh Kumar Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.
  • S Jahnavi Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.
  • G Reena Priyadarshini Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.
  • K Swathi Priya Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.
  • D Niveditha Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

Abstract

Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. This study was carried out with an objective to determine the efficacy of Metformin with other oral hypoglycemic agents, to educate the patients about the disease and use of drugs in diabetes mellitus and to evaluate which class of drugs in oral hypoglycemic agents with Metformin shows more effectiveness. The patients in each group received the medication for 8 weeks duration. A study was carried out about the comparative, efficacy of glimepiride and metformin in type-2 DM which was a meta-analysis of randomized controlled trials. The results of the study were that metformin alone does not show the efficacy than with Metformin+ Teneligliptin and Metformin + Glimepiride in overall efficacy of controlling FBS and PPBS. Combination of Metformin+ Glimepiride is more effective than Metformin+ Teneligliptin and Metformin alone. The findings from the study observed the combination of metformin efficacy to some extent.

Keywords: Metformin, Glimepiride, Teneligliptin, diabetes mellitus, randomized controlled trials

Downloads

Download data is not yet available.

Author Biographies

M Ganesh Kumar, Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

S Jahnavi, Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

G Reena Priyadarshini, Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

K Swathi Priya, Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

D Niveditha , Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

Department of Pharmacy Practice, Srinivasa Rao College of Pharmacy, Visakhapatnam, Andhra Pradesh, India.

References

1. Hermann LS, Scherstén B, Bitzén PO, Kjellström T, Lindgärde F, Melander A. Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled study. Diabetes Care. 1994 Oct 1;17(10):1100–9.
2. Hans N. The Efficacy and Safety of Teneligliptin and Metformin versus Glimepiride and Metformin in Patients of Type-2 Diabetes Mellitus Uncontrolled with Monotherapy. J Diabetes Metab. 2019 Jul 22;10(6):1–9.
3. Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: An overview. Avicenna J Med. 2020 Dec;10(4):174.
4. Pathophysiology of Type 2 Diabetes Mellitus - PMC [Internet]. [cited 2023 Mar 18]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503727/
5. Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC. Teneligliptin in management of type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2016 Aug 16;9:251–60.
6. Concepcion JQ, Tucker L, Huang K. Metformin for pediatric obesity and insulin resistance: a retrospective study within an integrated health care system. Obesity. 2021 Sep;29(9):1526–37.
7. Sadeghi A, Mousavi SM, Mokhtari T, Parohan M, Milajerdi A. Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta- Analysis of Randomized Clinical Trials. Child Obes. 2020 Apr 1;16(3):174–91.
8. Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care. 2007 Apr;30(4):790–4.
9. Ferrannini E, DeFronzo RA. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes. Eur Heart J. 2015 Sep 7;36(34):2288–96.
10. Kooy A, de Jager J, Lehert P, Bets D, Wulffelé MG, Donker AJM, et al. Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus. Arch Intern Med. 2009 Mar 23;169(6):616.
11. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016 Apr 1;101(4):1754–61.
12. Kim H soon, Kim D man, Cha B soo, Park TS, Kim K ah, Kim D lim, et al. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea. J Diabetes Investig. 2014 Nov;5(6):701–8.
13. Epidemiological factors for type 2 diabetes mellitus: evidence from the Global Burden of Disease - PMC [Internet]. [cited 2023 Mar 20]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218426/
14. Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, et al. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metab. 2016 Apr;23(4):591–601.
15. Sahay RK, Mittal V, Gopal GR, Kota S, Goyal G, Abhyankar M, et al. Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence. Cureus. 12(9):e10700.
Published
23-12-2023
Statistics
163 Views | 148 Downloads
Citatons
How to Cite
1.
M GK, S J, G RP, K SP, D N. A prospective observational study on safety and efficacy of metformin and its combination used in type-ii diabetes mellitus patients. World Journal of Current Med and Pharm Research [Internet]. 2023Dec.23 [cited 2025Feb.9];5(6):285-8. Available from: https://wjcmpr.com/index.php/journal/article/view/310
Section
Research Articles